Information:
Error:
ID
37147
Description
Real World Effectiveness of Abatacept in Rheumatoid Arthritis Patients: a Prospective, Single-arm, Open-label, Multi-center Observational Study in Taiwan; ODM derived from: https://clinicaltrials.gov/show/NCT02335606
Link
https://clinicaltrials.gov/show/NCT02335606
Keywords
Versions (1)
- 7/4/19 7/4/19 -
Copyright Holder
See clinicaltrials.gov
Uploaded on
July 4, 2019
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Rheumatoid Arthritis NCT02335606
Eligibility Rheumatoid Arthritis NCT02335606
- StudyEvent: Eligibility
Similar models
Eligibility Rheumatoid Arthritis NCT02335606
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Age
Item
≥ 20 years of age
boolean
C0001779 (UMLS CUI [1])
Informed Consent
Item
who give informed consent
boolean
C0021430 (UMLS CUI [1])
Rheumatoid Arthritis
Item
confirmed diagnosis of ra (as defined by american college of rheumatology revised 1987 criteria) and has ≥ 4 of the criteria listed below for ≥6 weeks before study enrollment
boolean
C0003873 (UMLS CUI [1])
Self-pay | Reimbursement National Health Insurance | abatacept
Item
who self-pay or who are reimbursed by bnhi for abatacept treatment
boolean
C3530213 (UMLS CUI [1])
C0021684 (UMLS CUI [2,1])
C0027452 (UMLS CUI [2,2])
C1619966 (UMLS CUI [3])
C0021684 (UMLS CUI [2,1])
C0027452 (UMLS CUI [2,2])
C1619966 (UMLS CUI [3])
Latent Tuberculosis | Antitubercular Agents U/day | Adherence Risk Management Plan
Item
with latent tb or who are receiving anti-tb treatment (inh 300 mg, qd) 1 month prior to using abatacept and continuously up to a total of 9 months willing to follow taiwan risk management plan guidelines as required by taiwan health authorities
boolean
C1609538 (UMLS CUI [1])
C0003448 (UMLS CUI [2,1])
C0456683 (UMLS CUI [2,2])
C1510802 (UMLS CUI [3,1])
C2699091 (UMLS CUI [3,2])
C0003448 (UMLS CUI [2,1])
C0456683 (UMLS CUI [2,2])
C1510802 (UMLS CUI [3,1])
C2699091 (UMLS CUI [3,2])
Abatacept | Abatacept Absent | Abatacept Initiation
Item
are being treated with abatacept or are abatacept treatment naïve and are initiating abatacept therapy
boolean
C1619966 (UMLS CUI [1])
C1619966 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C1619966 (UMLS CUI [3,1])
C1704686 (UMLS CUI [3,2])
C1619966 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C1619966 (UMLS CUI [3,1])
C1704686 (UMLS CUI [3,2])
Pregnancy | Breast Feeding
Item
pregnant or breast feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
Tuberculosis
Item
with active tb
boolean
C0041296 (UMLS CUI [1])
Hepatitis B surface antigen positive | Hepatitis C Antibodies Positive | Hepatitis B DNA assay positive
Item
hbsag (+)and/or anti-hcv(+) and/or hbv dna(+)
boolean
C0149709 (UMLS CUI [1])
C0166049 (UMLS CUI [2,1])
C1514241 (UMLS CUI [2,2])
C1168040 (UMLS CUI [3])
C0166049 (UMLS CUI [2,1])
C1514241 (UMLS CUI [2,2])
C1168040 (UMLS CUI [3])
Malignant Neoplasms | Exception Malignant Neoplasm Treated | Exception Neoplasm Free of Duration
Item
have cancer (patients who were treated and have no sign of cancer for > 10 years can be included)
boolean
C0006826 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0006826 (UMLS CUI [2,2])
C1522326 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C0006826 (UMLS CUI [3,2])
C0332296 (UMLS CUI [3,3])
C0449238 (UMLS CUI [3,4])
C1705847 (UMLS CUI [2,1])
C0006826 (UMLS CUI [2,2])
C1522326 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C0006826 (UMLS CUI [3,2])
C0332296 (UMLS CUI [3,3])
C0449238 (UMLS CUI [3,4])
Hypersensitivity Abatacept
Item
are allergic to abatacept
boolean
C0020517 (UMLS CUI [1,1])
C1619966 (UMLS CUI [1,2])
C1619966 (UMLS CUI [1,2])
Study Subject Participation Status
Item
enrolled in other ra clinical studies
boolean
C2348568 (UMLS CUI [1])